title: TAK-652, a novel CCR5 inhibitor, has favourable drug interactions with other antiretrovirals in vitro.
authors.forename: Cécile L
authors.initials: CL
authors.lastname: Tremblay
authors.forename: Françoise
authors.initials: F
authors.lastname: Giguel
authors.forename: Ting-Chao
authors.initials: TC
authors.lastname: Chou
authors.forename: Huajin
authors.initials: H
authors.lastname: Dong
authors.forename: Katsunori
authors.initials: K
authors.lastname: Takashima
authors.forename: Martin S
authors.initials: MS
authors.lastname: Hirsch
mesh_terms: D044966:Anti-Retroviral Agents / Q000494:pharmacology*; D065100:CCR5 Receptor Antagonists; D002478:Cells, Cultured; D004357:Drug Synergism; D015497:HIV-1 / Q000187:drug effects*; D007093:Imidazoles / Q000494:pharmacology*; D013454:Sulfoxides
chemical_list: D044966:Anti-Retroviral Agents; D065100:CCR5 Receptor Antagonists; D007093:Imidazoles; D013454:Sulfoxides; C506967:cenicriviroc